Pharmacology Quiz: Nitrates And Antianginal Therapy
20 questions · exam conditions
0:00
Nitrates And Antianginal TherapyQuestion 1 of 20

A patient with a non-ST-elevation myocardial infarction (NSTEMI) is receiving intravenous nitroglycerin for ongoing chest pain. The physician decides to also initiate intravenous metoprolol. The combined hemodynamic effect of these two agents is intended to optimize the myocardial oxygen supply/demand balance. However, a potential adverse outcome that must be monitored closely is:

a synergistic increase in heart rate, exacerbating ischemia.
excessive afterload reduction leading to coronary steal phenomenon.
coronary vasospasm due to unopposed alpha-adrenergic stimulation.
severe hypotension due to combined effects on vasodilation and cardiac output.
← Back to quizzes

Pharmacology Quiz

Pharmacology Quiz: Nitrates And Antianginal Therapy

Practice Nitrates And Antianginal Therapy in Pharmacology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Nitrates And Antianginal Therapy, giving you a quick way to practice the rules, question types, and explanations that matter most for Pharmacology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A patient with a non-ST-elevation myocardial infarction (NSTEMI) is receiving intravenous nitroglycerin for ongoing chest pain. The physician decides to also initiate intravenous metoprolol. The combined hemodynamic effect of these two agents is intended to optimize the myocardial oxygen supply/demand balance. However, a potential adverse outcome that must be monitored closely is:

  1. a synergistic increase in heart rate, exacerbating ischemia.
  2. excessive afterload reduction leading to coronary steal phenomenon.
  3. coronary vasospasm due to unopposed alpha-adrenergic stimulation.
  4. severe hypotension due to combined effects on vasodilation and cardiac output. (correct answer)
Explanation: When you encounter questions about drug combinations in acute coronary syndromes, focus on how each medication affects the cardiovascular system and what happens when their effects combine. Nitroglycerin and metoprolol both reduce myocardial oxygen demand but through different mechanisms. Nitroglycerin primarily causes venodilation (reducing preload) and some arterial dilation (reducing afterload), while metoprolol blocks beta-adrenergic receptors, decreasing heart rate, contractility, and blood pressure. Both medications independently lower blood pressure, and when used together, their hypotensive effects can be additive or even synergistic. This creates the primary risk of severe hypotension, especially since metoprolol also reduces cardiac output by decreasing both heart rate and contractility. Option A is incorrect because metoprolol is a beta-blocker that decreases heart rate, not increases it. Option B misapplies the coronary steal concept - while nitroglycerin can theoretically cause coronary steal, this isn't the primary concern with this combination, and metoprolol doesn't significantly affect afterload. Option C describes a mechanism that doesn't apply here since metoprolol blocks beta receptors but doesn't enhance alpha-adrenergic activity enough to cause coronary vasospasm. The correct answer is D because the combination of nitroglycerin's vasodilatory effects and metoprolol's reduction in cardiac output creates a significant risk for severe hypotension. Remember: whenever you see questions about combining cardiovascular medications, always consider the additive effects on blood pressure and cardiac output. These combinations often provide therapeutic benefits but require careful monitoring for excessive hypotension.

Question 2

A 45-year-old female experiences episodes of chest pain that occur at rest, typically in the early morning, and are associated with transient ST-segment elevation on ECG.

She is diagnosed with variant (Prinzmetal's) angina. Which of the following is the most important mechanism by which nitrates are effective in treating this condition?

  1. Reduction of myocardial oxygen demand by decreasing ventricular preload.
  2. Prevention of platelet aggregation at the site of coronary spasm.
  3. Direct relaxation of smooth muscle in large epicardial coronary arteries. (correct answer)
  4. Negative inotropic effects that reduce myocardial contractility and wall stress.
Explanation: Variant angina is caused by focal spasm of large epicardial coronary arteries, which dramatically reduces myocardial oxygen supply. Nitrates are potent, direct vasodilators of vascular smooth muscle. Their primary benefit in variant angina is to relieve and prevent this coronary vasospasm, thereby restoring blood flow and oxygen supply to the myocardium. While they also reduce preload, the critical mechanism in this context is direct coronary vasodilation.

Question 3

A patient beginning therapy with isosorbide dinitrate for angina prophylaxis reports a persistent, throbbing headache. This adverse effect is a direct consequence of the drug's action on which of the following vascular beds?

  1. Cerebral arterioles and venules. (correct answer)
  2. Coronary collateral vessels.
  3. Systemic capacitance veins.
  4. Pulmonary arteries.
Explanation: Headache is the most common side effect of nitrate therapy. It is caused by the potent vasodilatory effect of nitrates on cerebral and meningeal blood vessels. This dilation increases cerebral blood flow and can stretch pain-sensitive intracranial structures, leading to a characteristic throbbing headache. While nitrates act on other vascular beds to produce their therapeutic effects (veins) or other side effects (hypotension), the headache is specifically due to their action on the cranial vasculature.

Question 4

A 72-year-old female with chronic stable angina and type 2 diabetes is not achieving adequate symptom control with a beta-blocker and a calcium channel blocker. Her blood pressure is 110/70 mmHg and heart rate is 58 bpm.

Ranolazine is added to her regimen. How does the antianginal effect of ranolazine differ from that of traditional agents like nitrates or beta-blockers?

  1. It produces significant peripheral vasodilation, thereby reducing both preload and afterload.
  2. It selectively blocks the funny current (I_f) in the sinoatrial node to reduce heart rate.
  3. It reduces intracellular calcium overload by inhibiting the late inward sodium current in cardiomyocytes. (correct answer)
  4. It enhances the production of nitric oxide by providing an exogenous source of sulfhydryl groups.
Explanation: Ranolazine has a unique mechanism of action among antianginal drugs. It inhibits the late phase of the inward sodium current (late I_Na) in cardiomyocytes. This reduces intracellular sodium accumulation, which in turn reduces calcium influx via the sodium-calcium exchanger. The resulting decrease in intracellular calcium overload improves diastolic relaxation and reduces myocardial oxygen consumption without significantly affecting heart rate or blood pressure, making it useful in patients like this who are already at their hemodynamic limits.

Question 5

A 60-year-old patient with chronic stable angina is in normal sinus rhythm with a resting heart rate of 85 bpm despite being on a maximum tolerated dose of metoprolol. He continues to have angina.

Ivabradine is considered as an add-on therapy. The addition of ivabradine is expected to be beneficial primarily by:

  1. decreasing myocardial contractility (negative inotropy) to reduce cardiac workload.
  2. causing coronary and peripheral vasodilation to reduce afterload and increase coronary flow.
  3. inhibiting the late sodium current to reduce intracellular calcium overload.
  4. selectively reducing sinoatrial node firing rate to decrease heart rate and myocardial oxygen demand. (correct answer)
Explanation: Ivabradine is a heart rate-lowering agent that acts by selectively inhibiting the I_f ('funny') current in the sinoatrial (SA) node. This current is crucial for controlling the rate of spontaneous diastolic depolarization, and its inhibition slows the firing rate of the SA node. This leads to a pure reduction in heart rate without affecting myocardial contractility, atrioventricular conduction, or blood pressure. By lowering the heart rate, ivabradine reduces myocardial oxygen demand and increases diastolic perfusion time, providing antianginal benefit.

Question 6

A patient with a history of angina is prescribed both sublingual nitroglycerin tablets for acute attacks and a long-acting oral isosorbide mononitrate tablet for prophylaxis. The significant difference in the onset of action between these two formulations is primarily due to avoidance of what process by the sublingual route?

  1. Glucuronidation in the intestinal wall.
  2. First-pass hepatic metabolism. (correct answer)
  3. Binding to plasma albumin.
  4. Excretion by renal tubular secretion.
Explanation: Sublingual administration allows the drug to be absorbed directly through the oral mucosa into the systemic venous circulation. This route bypasses the portal circulation and the liver, thus avoiding extensive first-pass hepatic metabolism. Oral nitrates, in contrast, are absorbed from the gut and pass through the liver, where they are heavily metabolized, reducing their bioavailability and slowing their onset of action. This is why the sublingual route is used for rapid relief of acute angina.

Question 7

A patient is brought to the emergency department with cyanosis, dyspnea, and chocolate-brown colored blood after receiving a prolonged, high-dose intravenous nitroglycerin infusion for hypertensive emergency. Laboratory analysis reveals a methemoglobin level of 25%. This toxicity occurs because a metabolite of nitroglycerin:

  1. directly inhibits cytochrome c oxidase, leading to cellular hypoxia.
  2. causes oxidative damage to red blood cell membranes, leading to acute hemolysis.
  3. oxidizes the ferrous iron (Fe²⁺) in hemoglobin to ferric iron (Fe³⁺). (correct answer)
  4. displaces oxygen from hemoglobin with a much higher affinity.
Explanation: Methemoglobinemia is a rare but serious complication of high-dose nitrate therapy. Nitrates are metabolized to nitric oxide and related species that can oxidize the ferrous iron (Fe²⁺) in the heme portion of hemoglobin to its ferric state (Fe³⁺). The resulting molecule, methemoglobin, is incapable of binding and transporting oxygen, leading to functional anemia and tissue hypoxia, which manifests as cyanosis.

Question 8

A patient with stable exertional angina is prescribed sublingual nitroglycerin. The primary mechanism by which this agent alleviates acute anginal symptoms is a reduction in myocardial oxygen demand secondary to which of the following?

  1. A decrease in systemic vascular resistance, reducing afterload.
  2. A direct increase in collateral blood flow to ischemic myocardial tissue.
  3. A reduction in left ventricular end-diastolic volume, reducing preload. (correct answer)
  4. A negative chronotropic effect, decreasing the heart rate.
Explanation: Nitroglycerin is a potent venodilator, which decreases venous return to the heart. This leads to a reduction in left ventricular end-diastolic volume and pressure (preload). According to the Law of Laplace, reduced preload decreases ventricular wall stress, which is a major determinant of myocardial oxygen consumption. This reduction in oxygen demand is the primary antianginal mechanism in stable angina.

Question 9

After several days of continuous nitroglycerin infusion, a patient shows a diminished hemodynamic response, a phenomenon known as nitrate tolerance. Current evidence suggests a key multifactorial basis for this tolerance, including increased activity of which counter-regulatory system?

  1. Parasympathetic nervous system activation, leading to bradycardia.
  2. The renin-angiotensin-aldosterone system (RAAS), leading to vasoconstriction and volume expansion. (correct answer)
  3. Endothelial nitric oxide synthase (eNOS) upregulation, leading to enhanced endogenous vasodilation.
  4. Inhibition of phosphodiesterase type 3 (PDE-3), leading to cGMP accumulation.
Explanation: The development of nitrate tolerance is complex, but a major contributing factor is neurohormonal counter-regulation. The persistent vasodilation and drop in blood pressure caused by continuous nitrate administration trigger a compensatory activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS). This leads to increased levels of vasoconstrictors (e.g., angiotensin II, norepinephrine) and volume retention (via aldosterone), which oppose the vasodilatory effects of nitroglycerin and contribute to the attenuated response.

Question 10

A patient with stable exertional angina is prescribed sublingual nitroglycerin. The primary mechanism by which this agent alleviates acute anginal symptoms is a reduction in myocardial oxygen demand secondary to which of the following?

  1. A decrease in systemic vascular resistance, reducing afterload.
  2. A direct increase in collateral blood flow to ischemic myocardial tissue.
  3. A reduction in left ventricular end-diastolic volume, reducing preload. (correct answer)
  4. A negative chronotropic effect, decreasing the heart rate.
Explanation: Nitroglycerin is a potent venodilator, which decreases venous return to the heart. This leads to a reduction in left ventricular end-diastolic volume and pressure (preload). According to the Law of Laplace, reduced preload decreases ventricular wall stress, which is a major determinant of myocardial oxygen consumption. This reduction in oxygen demand is the primary antianginal mechanism in stable angina.

Question 11

An 80-year-old male with severe aortic stenosis presents with an episode of exertional chest pain. His blood pressure is 140/85 mmHg. The use of nitroglycerin in this patient must be approached with extreme caution primarily because:

  1. it can cause a paradoxical increase in afterload by stimulating the renin-angiotensin system.
  2. patients with aortic stenosis are often dependent on elevated preload to maintain cardiac output across the fixed obstruction. (correct answer)
  3. it can precipitate coronary vasospasm in patients with valvular heart disease.
  4. it is rapidly metabolized by the liver, producing toxic levels of thiocyanate.
Explanation: In severe aortic stenosis, the stenotic valve creates a fixed obstruction to left ventricular outflow. To overcome this, the ventricle hypertrophies and becomes stiff, requiring a high filling pressure (preload) to generate adequate stroke volume. Nitroglycerin's potent venodilating effect can cause a sudden and dramatic drop in preload. This can lead to a critical reduction in cardiac output, resulting in severe hypotension, syncope, and worsening myocardial ischemia.

Question 12

A 45-year-old female experiences episodes of chest pain that occur at rest, typically in the early morning, and are associated with transient ST-segment elevation on ECG.

She is diagnosed with variant (Prinzmetal's) angina. Which of the following is the most important mechanism by which nitrates are effective in treating this condition?

  1. Reduction of myocardial oxygen demand by decreasing ventricular preload.
  2. Prevention of platelet aggregation at the site of coronary spasm.
  3. Direct relaxation of smooth muscle in large epicardial coronary arteries. (correct answer)
  4. Negative inotropic effects that reduce myocardial contractility and wall stress.
Explanation: Variant angina is caused by focal spasm of large epicardial coronary arteries, which dramatically reduces myocardial oxygen supply. Nitrates are potent, direct vasodilators of vascular smooth muscle. Their primary benefit in variant angina is to relieve and prevent this coronary vasospasm, thereby restoring blood flow and oxygen supply to the myocardium. While they also reduce preload, the critical mechanism in this context is direct coronary vasodilation.

Question 13

A patient with a history of angina is prescribed both sublingual nitroglycerin tablets for acute attacks and a long-acting oral isosorbide mononitrate tablet for prophylaxis. The significant difference in the onset of action between these two formulations is primarily due to avoidance of what process by the sublingual route?

  1. Glucuronidation in the intestinal wall.
  2. First-pass hepatic metabolism. (correct answer)
  3. Binding to plasma albumin.
  4. Excretion by renal tubular secretion.
Explanation: Sublingual administration allows the drug to be absorbed directly through the oral mucosa into the systemic venous circulation. This route bypasses the portal circulation and the liver, thus avoiding extensive first-pass hepatic metabolism. Oral nitrates, in contrast, are absorbed from the gut and pass through the liver, where they are heavily metabolized, reducing their bioavailability and slowing their onset of action. This is why the sublingual route is used for rapid relief of acute angina.

Question 14

After several days of continuous nitroglycerin infusion, a patient shows a diminished hemodynamic response, a phenomenon known as nitrate tolerance. Current evidence suggests a key multifactorial basis for this tolerance, including increased activity of which counter-regulatory system?

  1. Parasympathetic nervous system activation, leading to bradycardia.
  2. The renin-angiotensin-aldosterone system (RAAS), leading to vasoconstriction and volume expansion. (correct answer)
  3. Endothelial nitric oxide synthase (eNOS) upregulation, leading to enhanced endogenous vasodilation.
  4. Inhibition of phosphodiesterase type 3 (PDE-3), leading to cGMP accumulation.
Explanation: The development of nitrate tolerance is complex, but a major contributing factor is neurohormonal counter-regulation. The persistent vasodilation and drop in blood pressure caused by continuous nitrate administration trigger a compensatory activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS). This leads to increased levels of vasoconstrictors (e.g., angiotensin II, norepinephrine) and volume retention (via aldosterone), which oppose the vasodilatory effects of nitroglycerin and contribute to the attenuated response.

Question 15

While both calcium channel blockers (CCBs) and nitrates are effective in treating variant (Prinzmetal's) angina, what is a key advantage of using a long-acting CCB like amlodipine over long-acting nitrates for prophylaxis in this condition?

  1. CCBs provide a greater reduction in myocardial preload than nitrates.
  2. The development of pharmacological tolerance is less common and clinically significant with CCBs. (correct answer)
  3. CCBs have a more rapid onset of action for aborting acute vasospastic attacks.
  4. Nitrates are more likely to cause peripheral edema as a side effect.
Explanation: A major limitation of continuous or frequent use of long-acting nitrates is the development of pharmacologic tolerance, which attenuates their therapeutic effect and necessitates a daily nitrate-free interval. Calcium channel blockers do not exhibit this phenomenon of tachyphylaxis or tolerance, making them a more reliable option for consistent, long-term prophylaxis of vasospastic angina.

Question 16

A 70-year-old woman with exertional angina also has a diagnosis of heart failure with preserved ejection fraction (HFpEF), characterized by diastolic dysfunction and elevated left ventricular filling pressures.

How does isosorbide mononitrate primarily improve her anginal symptoms in the context of her HFpEF?

  1. By increasing myocardial contractility, which improves the ejection fraction and reduces end-systolic volume.
  2. By reducing venous return, which lowers left ventricular end-diastolic pressure and alleviates diastolic wall stress. (correct answer)
  3. By directly relaxing the stiff ventricular myocardium, thus improving diastolic compliance.
  4. By significantly lowering systemic blood pressure, which reduces afterload and allows for more complete ventricular emptying.
Explanation: The pathophysiology of HFpEF involves a stiff, non-compliant left ventricle, leading to high filling pressures (left ventricular end-diastolic pressure, LVEDP) for any given volume. This elevated LVEDP increases diastolic wall stress, which can compress subendocardial vessels and contribute to angina. Nitrates are potent venodilators that decrease venous return (preload). This action directly lowers the elevated LVEDP, reducing diastolic wall stress and thereby alleviating both anginal symptoms and pulmonary congestion.

Question 17

A 59-year-old male presents to the emergency department with severe, crushing chest pain. His ECG is consistent with an acute ST-elevation myocardial infarction. He is immediately given aspirin and a P2Y12 inhibitor. When the physician considers administering sublingual nitroglycerin for chest pain and preload reduction, the patient mentions he took a dose of sildenafil for erectile dysfunction about 12 hours ago.

Administration of nitroglycerin in this patient would most likely lead to which of the following?

  1. Severe, refractory hypotension due to synergistic increases in cGMP. (correct answer)
  2. An acute coronary vasospasm due to a paradoxical drug interaction.
  3. The development of methemoglobinemia due to altered nitric oxide metabolism.
  4. A significant reduction in the antiplatelet effect of aspirin and the P2Y12 inhibitor.
Explanation: Nitrates increase the production of cyclic guanosine monophosphate (cGMP) by activating guanylate cyclase, leading to vasodilation. Sildenafil is a phosphodiesterase-5 (PDE-5) inhibitor, which prevents the breakdown of cGMP. Their concurrent use leads to a synergistic and profound accumulation of cGMP, causing massive vasodilation and potentially life-threatening hypotension. This combination is absolutely contraindicated.

Question 18

A 60-year-old patient with chronic stable angina is in normal sinus rhythm with a resting heart rate of 85 bpm despite being on a maximum tolerated dose of metoprolol. He continues to have angina.

Ivabradine is considered as an add-on therapy. The addition of ivabradine is expected to be beneficial primarily by:

  1. decreasing myocardial contractility (negative inotropy) to reduce cardiac workload.
  2. causing coronary and peripheral vasodilation to reduce afterload and increase coronary flow.
  3. inhibiting the late sodium current to reduce intracellular calcium overload.
  4. selectively reducing sinoatrial node firing rate to decrease heart rate and myocardial oxygen demand. (correct answer)
Explanation: Ivabradine is a heart rate-lowering agent that acts by selectively inhibiting the I_f ('funny') current in the sinoatrial (SA) node. This current is crucial for controlling the rate of spontaneous diastolic depolarization, and its inhibition slows the firing rate of the SA node. This leads to a pure reduction in heart rate without affecting myocardial contractility, atrioventricular conduction, or blood pressure. By lowering the heart rate, ivabradine reduces myocardial oxygen demand and increases diastolic perfusion time, providing antianginal benefit.

Question 19

A 70-year-old woman with exertional angina also has a diagnosis of heart failure with preserved ejection fraction (HFpEF), characterized by diastolic dysfunction and elevated left ventricular filling pressures.

How does isosorbide mononitrate primarily improve her anginal symptoms in the context of her HFpEF?

  1. By increasing myocardial contractility, which improves the ejection fraction and reduces end-systolic volume.
  2. By reducing venous return, which lowers left ventricular end-diastolic pressure and alleviates diastolic wall stress. (correct answer)
  3. By directly relaxing the stiff ventricular myocardium, thus improving diastolic compliance.
  4. By significantly lowering systemic blood pressure, which reduces afterload and allows for more complete ventricular emptying.
Explanation: The pathophysiology of HFpEF involves a stiff, non-compliant left ventricle, leading to high filling pressures (left ventricular end-diastolic pressure, LVEDP) for any given volume. This elevated LVEDP increases diastolic wall stress, which can compress subendocardial vessels and contribute to angina. Nitrates are potent venodilators that decrease venous return (preload). This action directly lowers the elevated LVEDP, reducing diastolic wall stress and thereby alleviating both anginal symptoms and pulmonary congestion.

Question 20

A physician prescribes both metoprolol and a long-acting nitrate for a patient with frequent exertional angina. A primary pharmacodynamic rationale for this combination therapy is that metoprolol can attenuate which common, undesirable side effect of nitrate monotherapy?

  1. Throbbing headache.
  2. Postural hypotension.
  3. Development of pharmacologic tolerance.
  4. Reflex tachycardia. (correct answer)
Explanation: When you encounter combination therapy questions in pharmacology, think about how drugs can complement each other by counteracting each other's side effects or enhancing therapeutic benefits. Nitrates like isosorbide mononitrate are potent vasodilators that reduce cardiac preload and afterload, making them excellent for angina prevention. However, nitrate-induced vasodilation triggers a compensatory response: when blood pressure drops due to vasodilation, the sympathetic nervous system activates to maintain cardiac output, resulting in reflex tachycardia. This increased heart rate can actually worsen angina by increasing myocardial oxygen demand – counterproductive for an anti-anginal medication. Metoprolol, a selective β1-adrenergic blocker, directly counters this reflex tachycardia by blocking sympathetic stimulation of the heart. This combination is synergistic: nitrates provide vasodilation while metoprolol prevents the harmful compensatory increase in heart rate. Let's examine why the other options don't represent the primary rationale: (A) Throbbing headache from nitrates is caused by cerebral vasodilation, which metoprolol doesn't prevent. (B) Postural hypotension results from venodilation and reduced venous return – metoprolol doesn't counteract this and may actually worsen hypotension through its own blood pressure-lowering effects. (C) Nitrate tolerance develops from vascular desensitization to nitric oxide, not from sympathetic activation, so β-blockers don't prevent it. Remember this pattern: when vasodilators are combined with β-blockers, the β-blocker typically serves to prevent reflex tachycardia – a key concept for cardiovascular pharmacology questions.